| [1] | Corner BE, Magee PT (1997) Candida pathogenicity: unravelling the threads of infection. Curr Biol 7: R691–R694.
|
| [2] | Wenzel RP, Gennings C (2005) Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis 41: S389–S393.
|
| [3] | Bustamante CI (2005) Treatment of Candida infection: a view from the trenches! Curr Opin Infect Dis. 18: 490–495.
|
| [4] | Miceli MH, Diaz JA, Lee SA (2011) Emerging opportunistic yeast infections. Lancet Infect Dis 11: 142–151.
|
| [5] | Ghannoum MA, Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501–507.
|
| [6] | Tournu H, Serneels J, van Dijck P (2005) Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets. Curr Drug Targets 6: 909–922.
|
| [7] | Morschh？user J (2010) Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47: 94–106.
|
| [8] | Kumamoto CA, Vinces MD (2005) Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 7: 1546–1554.
|
| [9] | Whiteway M, Bachewich C (2007) Morphogenesis in Candida albicans. Annu Rev Microbiol 61: 529–553.
|
| [10] | Cottier F, Mühlschlegel FA (2009) Sensing the environment: Response of Candida albicans to the X factor. FEMS Microbiol Lett 295: 1–9.
|
| [11] | Biswas S, van Dijck P, Datta A (2007) Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71: 348–376.
|
| [12] | Han TL, Cannon RD, Villas-B？as SG (2011) The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet Biol 48: 747–763.
|
| [13] | Lo HJ, K？hler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939–949.
|
| [14] | Saville SP, Lazzell AL, Monteagudo C, López-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2: 1053–1060.
|
| [15] | Lorenz MC, Bender JA, Fink GR (2004) Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3: 1076–1087.
|
| [16] | ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W, de Groot PW (2009) Molecular and cellular mechanisms that lead to Candida biofilm formation. J Dent Res 88: 105–115.
|
| [17] | Dongari-Bagtzoglou A (2008) Pathogenesis of mucosal biofilms infections: challenges and progress. Expert Rev Anti Infect Ther 6: 201–208.
|
| [18] | Gauwerky K, Borelli C, Korting HC (2009) Targeting virulence: a new paradigm for antifungals. Drug Discov Today 14: 214–222.
|
| [19] | Arimoto-Kobayashi S, Machida M, Okamoto K, Yamaguchi A (2005) Evaluation of photo-mutagenicity and photo-cytotoxicity of food coloring agents. Mutagenesis 20: 229–233.
|
| [20] | Kang K, Fong WP, Tsang PWK (2010) Novel antifungal activity of purpurin against Candida species. Med Mycol 48: 904–911.
|
| [21] | Liu H, K？hler J, Fink GR (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723–1726.
|
| [22] | Bandara HMHN, Lam OLT, Watt RM, Jin LJ, Samaranayake LP (2010) Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species. J Med Microbiol 59: 1225–1234.
|
| [23] | Chandra J, Mukherjee PK, Ghannoum MA (2008) In vitro growth and analysis of Candida biofilms. Nat Protoc 3: 1909–1924.
|
| [24] | Schaller M, Sch？fer W, Korting HC, Hube B (1998) Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 29: 605–615.
|
| [25] | Xie Z, Thompson A, Kashleva H (2011) Dongari-Bagtzoglou (2011) A quantitative real-time RT-PCR assay for mature C. albicans biofilms. BMC Microbiol 11: 93.
|
| [26] | Uppuluri P, Chaturvedi AK, Lopez-Ribot JL (2009) Design of a simple model of Candida albicans biofilms formed under conditions of flow: development, architecture, and drug resistance. Mycopathologia 168: 101–109.
|
| [27] | Ríos JL, Recio MC (2005) Medicinal plants and antimicrobial activity. J Ethnopharmacol 100: 80–84.
|
| [28] | Di Santo R (2010) Natural products as antifungal agents against clinical relevant pathogens. Nat Prod Rep 27: 1084–1098.
|
| [29] | Taff HT, Nett JE, Andes DR (2012) Comparative analysis of Candida biofilms quantitation assays. Med Mycol 50: 214–218.
|
| [30] | Shareck J, Nantel A, Belhumeur P (2011) Conjugated linoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression. Eukaryot Cell 10: 565–577.
|
| [31] | Toenjes KA, Munsee SM, Ibrahim AS, Jeffrey R, Edwards JE Jr, et al. (2005) Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49: 963–972.
|
| [32] | Toenjes KA, Stark BC, Brooks KM, Johnson DI (2009) Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans. J Med Microbiol 58: 779–790.
|
| [33] | Shareck J, Belhumeur P (2011) Modulation of morphogenesis in Candida albicans by various small molecules. Eukaryot Cell 10: 1004–1012.
|
| [34] | Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17: 255–267.
|
| [35] | Finkel JS, Mitchell AP (2011) Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9: 109–118.
|
| [36] | Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, et al. (2008) Complementary adhesion function in C. albicans biofilm formation. Curr Biol 18: 1017–1024.
|
| [37] | Nobile CJ, Nett JE, Andes DR, Mitchell AP (2006) Function of Candida albicans adhesion Hwp1 in biofilms formation. Eukaryot Cell 5: 1604–1610.
|
| [38] | Bailey DA, Feldmann PJ, Bovey M, Gow NA, Brown AJ (1996) The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol 178: 5353–5360.
|
| [39] | Luo G, Ibrahim AS, Spellberg B, Nobile CJ, Mitchell AP, et al. (2010) Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis 201: 1718–1728.
|
| [40] | Luo G, Ibrahim AS, French SW, Edwards JE Jr, Fu Y (2011) Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis. PLoS One 6: e25909.
|
| [41] | Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, et al. (2006) Critical role of Bcr1-dependent adhesions in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog 2: e63.
|
